MUNVEER BHANGOO, MD
Medical Oncology Physician · LA JOLLA, CA
Individual Active NPI 1235499518
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,037 | 258,359 | $30,343,444 | $7,362,546 | $5,859,002 |
| 2023 | 719 | 167,347 | $21,025,731 | $5,057,157 | $4,018,106 |
| 2022 | 612 | 141,016 | $18,037,398 | $4,266,880 | $3,392,855 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 38,200 | $52 | $42 |
| J9299 | Injection, nivolumab, 1 mg | 36,120 | $30 | $24 |
| J9177 | Injection, enfortumab vedotin-ejfv, 0.25 mg | 22,480 | $35 | $28 |
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 14,340 | $0 | $0 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 14,250 | $1 | $1 |
| J0185 | Injection, aprepitant, 1 mg | 13,000 | $2 | $1 |
| J9025 | Injection, azacitidine, 1 mg | 11,630 | $0 | $0 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 6,300 | $19 | $15 |
| J0897 | Injection, denosumab, 1 mg | 5,280 | $25 | $20 |
| J9171 | Injection, docetaxel, 1 mg | 5,018 | $1 | $1 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 3,060 | $0 | $0 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,980 | $49 | $39 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | A128764 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in California
- NPI 1417120080
- NPI 1396994604
- NPI 1356327316
- NPI 1306909791
- NPI 1164497855
- NPI 1700088556
- NPI 1568750032
- NPI 1770961575
See all Medical Oncology Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.